Biophytis S.A.
OTC: BPTSY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Stanislas Veillet
- Employees
- 22
- Headquarters
- Paris, France
- IPO year
- 2021
- Market cap
- $105.2K
- Website
- https://www.biophytis.com
Loading BPTSY…
Loading profile data…Frequently asked questions about BPTSY
What does Biophytis S.A. (BPTSY) do?
Biophytis S.A. is a clinical-stage biotechnology firm dedicated to developing therapeutic interventions that slow the degenerative processes associated with age and improve functional outcomes for patients. The company's innovative treatments work by targeting and activating vital biological resilience pathways. These mechanisms are designed to...
Where does BPTSY trade?
Biophytis S.A. (BPTSY) trades on the Other OTC.
What sector is BPTSY in?
Biophytis S.A. (BPTSY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biophytis S.A.?
Stanislas Veillet is the chief executive officer of Biophytis S.A. (BPTSY).
Where is Biophytis S.A. headquartered?
Biophytis S.A. is headquartered in France.
Does BPTSY pay a dividend?
Biophytis S.A. (BPTSY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BPTSY go public?
Biophytis S.A. (BPTSY) completed its initial public offering in 2021.
Is BPTSY an ADR?
Yes — BPTSY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Biophytis S.A. reporting and dividends follow the underlying issuer.